Atea Pharmaceuticals (AVIR) Amortizatization of Intangibles (2022 - 2026)

Atea Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $581000.0 for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 66.61% year-over-year to $581000.0 in Q1 2026; TTM through Mar 2026 was $3.8 million, a 62.42% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 58.18% from the prior year.
• Amortizatization of Intangibles slipped to $581000.0 in Q1 2026 per AVIR's latest filing, from $808000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $7.9 million in Q4 2022 and bottomed at $581000.0 in Q1 2026.
• The 5-year median for Amortizatization of Intangibles is $2.9 million (2024), against an average of $2.9 million.
• Across the five-year window, Amortizatization of Intangibles gained 12.99% in 2024 and sank 70.22% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $7.9 million in 2022, then sank by 45.21% to $4.3 million in 2023, then slumped by 37.56% to $2.7 million in 2024, then sank by 70.22% to $808000.0 in 2025, then declined by 28.09% to $581000.0 in 2026.
• Per Business Quant, the three latest AVIR Amortizatization of Intangibles figures stand at $581000.0 (Q1 2026), $808000.0 (Q4 2025), and $1.1 million (Q3 2025).